State Street Corp Has $8.35 Million Stake in National Research Co. (NASDAQ:NRC)

State Street Corp lifted its position in National Research Co. (NASDAQ:NRC) by 4.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 363,438 shares of the company’s stock after buying an additional 14,144 shares during the quarter. State Street Corp owned about 1.52% of National Research worth $8,351,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Quarry LP bought a new stake in National Research in the 2nd quarter valued at $54,000. Benjamin F. Edwards & Company Inc. grew its position in National Research by 145.6% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 2,783 shares of the company’s stock worth $64,000 after buying an additional 1,650 shares in the last quarter. FMR LLC increased its stake in National Research by 397.3% during the third quarter. FMR LLC now owns 2,944 shares of the company’s stock valued at $67,000 after acquiring an additional 2,352 shares during the period. Gladius Capital Management LP raised its holdings in National Research by 164.5% in the 3rd quarter. Gladius Capital Management LP now owns 3,068 shares of the company’s stock valued at $70,000 after acquiring an additional 1,908 shares in the last quarter. Finally, Point72 Asset Management L.P. bought a new stake in shares of National Research in the 3rd quarter worth approximately $88,000. 47.26% of the stock is owned by institutional investors and hedge funds.

National Research Stock Performance

NRC opened at $17.43 on Friday. The stock’s 50 day simple moving average is $18.84 and its 200-day simple moving average is $21.26. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30. The stock has a market cap of $409.19 million, a PE ratio of 15.42 and a beta of 0.52. National Research Co. has a 1 year low of $16.74 and a 1 year high of $42.18.

National Research (NASDAQ:NRC) last issued its earnings results on Friday, October 25th. The company reported $0.24 earnings per share (EPS) for the quarter. The business had revenue of $35.82 million during the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%.

National Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.75%. The ex-dividend date of this dividend is Friday, December 27th. National Research’s dividend payout ratio (DPR) is currently 42.48%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.